McGill University Health Centre/Research Institute of the McGill University Health Centre: COVID-19 trials

The registry lists 12 COVID-19 studies with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 5Phase 3 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• COVID-19 Booster and IIV Schedule in Immunocompromised HostsRecruitingNCT06599658Phase 2
• A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa.RecruitingNCT05436795Phase 1/2
• Inhaled Ciclesonide for Outpatients With COVID19TerminatedNCT04435795Phase 2/3Results posted
• Virtual Physical Rehabilitation for Patients Living with Long COVIDCompletedNCT05298878Not applicable
• Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19Status unknownNCT04935476Phase 3
• Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal CellsTerminatedNCT04869397Phase 2
• COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune DiseasesCompletedNCT04806113Phase 3
• COVID-19 Immunologic Antiviral Therapy With OmalizumabStatus unknownNCT04720612Phase 2
• The McGill RAAS-COVID-19 TrialCompletedNCT04508985Not applicable
• The VOICE-COVID-19CompletedNCT04508972
• Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)TerminatedNCT04421664Phase 3
• DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)CompletedNCT04409925Phase 1